Posted on 5 April 2018
Professor Paul Kaye has recently started his role as the new chair of the Medical Research Council's Infections and Immunity Board.
Paul is a Professor of Immunology in the Centre for Immunology and Infection, working with the Department of Biology and Hull York Medical School. His research on the neglected tropical disease leishmaniasis is internationally recognised, and he has also contributed a great deal to our understanding of the impact of chronic infection on surrounding tissue.
As part of his research on leishmaniasis, Paul is currently leading a Phase II therapeutic vaccine trial in Sudan, funded by the Wellcome Trust, for whom he is a Senior Investigator. He is also an elected Fellow of the UK Academy of Medical Sciences.
Paul said of his appointment: “The MRC has supported my research for the past 30 years, and so it is an honour to be able to give something back and help to ensure that research on immunology and infection retains a prominent role within the new UK research landscape.”
MRC research boards and panels are made up of leading scientists, who work to deliver MRC objectives and manage scientific activity within their specialist areas.